ZENTRIP Trademark
ZENTRIP is a USPTO trademark filed by SATO PHARMACEUTICAL CO., LTD.. Status: Registered.
Prosecution Summary
Trademark Summary
The standard character mark ZENTRIP covers motion sickness drugs in International Class 005, with additional domestic classifications in classes 006, 018, 044, 046, 051, and 052. It is owned by SATO PHARMACEUTICAL CO., LTD., a Japanese corporation based in Tokyo. The mark is registered on the Principal Register (Reg. No. 3765088) and renewed for a first 10-year term, with Sections 8 and 15 affidavits accepted.
Recent Activity
Filed February 20, 2009, the application was published for opposition June 16, 2009, and registered March 23, 2010, after Statement of Use submission. It was most recently renewed May 14, 2020, following acceptance of Sections 8 and 9 filings.
Trademark Facts
| Mark | ZENTRIP |
|---|---|
| Serial Number | 77675206 |
| Registration Number | 3765088 |
| Status | Registered |
| Filing Date | 2009-02-20 |
| Registration Date | 2010-03-23 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | SATO PHARMACEUTICAL CO., LTD. |
| Attorney of Record | Lawrence E. Abelman |
| Prosecution Events | 27 |
| Latest Event | NA89 on 2020-05-14 |
Goods & Services
Motion sickness drugs